249 related articles for article (PubMed ID: 33710623)
1. Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications.
Baldassarre M; Naldi M; Zaccherini G; Bartoletti M; Antognoli A; Laggetta M; Gagliardi M; Tufoni M; Domenicali M; Waterstradt K; Paterini P; Baldan A; Leoni S; Bartolini M; Viale P; Trevisani F; Bernardi M; Caraceni P
Hepatology; 2021 Oct; 74(4):2058-2073. PubMed ID: 33710623
[TBL] [Abstract][Full Text] [Related]
2. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
[TBL] [Abstract][Full Text] [Related]
3. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
[TBL] [Abstract][Full Text] [Related]
4. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.
Ruiz-Margáin A; Pohlmann A; Ryan P; Schierwagen R; Chi-Cervera LA; Jansen C; Mendez-Guerrero O; Flores-García NC; Lehmann J; Torre A; Macías-Rodríguez RU; Trebicka J
Liver Transpl; 2018 May; 24(5):595-605. PubMed ID: 29476704
[TBL] [Abstract][Full Text] [Related]
6. Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis.
Trebicka J; Amoros A; Pitarch C; Titos E; Alcaraz-Quiles J; Schierwagen R; Deulofeu C; Fernandez-Gomez J; Piano S; Caraceni P; Oettl K; Sola E; Laleman W; McNaughtan J; Mookerjee RP; Coenraad MJ; Welzel T; Steib C; Garcia R; Gustot T; Rodriguez Gandia MA; Bañares R; Albillos A; Zeuzem S; Vargas V; Saliba F; Nevens F; Alessandria C; de Gottardi A; Zoller H; Ginès P; Sauerbruch T; Gerbes A; Stauber RE; Bernardi M; Angeli P; Pavesi M; Moreau R; Clària J; Jalan R; Arroyo V
Front Immunol; 2019; 10():476. PubMed ID: 30941129
[No Abstract] [Full Text] [Related]
7. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis.
Bajaj JS; Reddy KR; O'Leary JG; Vargas HE; Lai JC; Kamath PS; Tandon P; Wong F; Subramanian RM; Thuluvath P; Fagan A; White MB; Gavis EA; Sehrawat T; de la Rosa Rodriguez R; Thacker LR; Sikaroodi M; Garcia-Tsao G; Gillevet PM
Gastroenterology; 2020 Nov; 159(5):1715-1730.e12. PubMed ID: 32687928
[TBL] [Abstract][Full Text] [Related]
8. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
[TBL] [Abstract][Full Text] [Related]
9. Elevated neopterin levels are associated with acute-on-chronic liver failure and mortality in patients with liver cirrhosis.
Matiollo C; Rateke ECM; de Oliveira KG; Turnes BL; da Silva TE; Maccali C; Latini AS; Narciso-Schiavon JL; Schiavon LL
Dig Liver Dis; 2020 Jul; 52(7):753-760. PubMed ID: 32434738
[TBL] [Abstract][Full Text] [Related]
10. Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis.
Sundaram V; Jalan R; Ahn JC; Charlton MR; Goldberg DS; Karvellas CJ; Noureddin M; Wong RJ
J Hepatol; 2018 Sep; 69(3):617-625. PubMed ID: 29709681
[TBL] [Abstract][Full Text] [Related]
11. Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis.
López-Vicario C; Checa A; Urdangarin A; Aguilar F; Alcaraz-Quiles J; Caraceni P; Amorós A; Pavesi M; Gómez-Cabrero D; Trebicka J; Oettl K; Moreau R; Planell N; Arroyo V; Wheelock CE; Clària J
J Hepatol; 2020 Oct; 73(4):817-828. PubMed ID: 32294533
[TBL] [Abstract][Full Text] [Related]
12. Pro-adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Yan H; Jin S; Liang L; Du J; Aithal GP; Li L
Scand J Gastroenterol; 2020 May; 55(5):606-614. PubMed ID: 32476510
[No Abstract] [Full Text] [Related]
13. Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule.
Baldassarre M; Domenicali M; Naldi M; Laggetta M; Giannone FA; Biselli M; Patrono D; Bertucci C; Bernardi M; Caraceni P
Sci Rep; 2016 Oct; 6():35987. PubMed ID: 27782157
[TBL] [Abstract][Full Text] [Related]
14. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.
Horvatits T; Drolz A; Roedl K; Rutter K; Ferlitsch A; Fauler G; Trauner M; Fuhrmann V
Liver Int; 2017 Feb; 37(2):224-231. PubMed ID: 27416294
[TBL] [Abstract][Full Text] [Related]
15. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
[TBL] [Abstract][Full Text] [Related]
16. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients.
Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ
World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.
Narciso-Schiavon JL; Pereira JG; Silva TE; Bansho ETO; Morato EF; Pinheiro JT; Muraro-Wildner L; Bazzo ML; Dantas-Corrêa EB; Schiavon LL
Ann Hepatol; 2017; 16(5):780-787. PubMed ID: 28809733
[TBL] [Abstract][Full Text] [Related]
18. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP
Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128
[TBL] [Abstract][Full Text] [Related]
19. Serum Ammonia is Associated With Transplant-free Survival in Hospitalized Patients With Acutely Decompensated Cirrhosis [corrected].
Patwardhan VR; Jiang ZG; Risech-Neiman Y; Piatkowski G; Afdhal NH; Mukamal K; Curry MP; Tapper EB
J Clin Gastroenterol; 2016 Apr; 50(4):345-50. PubMed ID: 26565968
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of patients with hepatitis B virus-related acute on chronic liver failure: An observational cohort study.
Lin S; Zhang K; Zhang J; Wang M; Velani B; Zhu Y
Liver Int; 2019 May; 39(5):854-860. PubMed ID: 30753752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
